Drugs & Side Effects |

Cancer Drugs News

Cervical Cancer Vaccine Expected to be Approved

RSS News Feeds
Drugs & Pharmacuticals
Cancer Drugs
Fosamax
 All RSS Feeds

At a glance:

An FDA advisory committee recommends approval of Merck's new cervical cancer vaccine, Gardasil, with a final decision to be made in June. 
 
The vaccine is expected to be effective against the forms of Human Papilloma Virus (HPV) that cause 70% of cases of cancer of the cervix, and 90% of cases of genital warts. 
 
The vaccine appears to be safe and effective but since it doesn't cover all varieties of the virus, regular screening (pap smears)is still necessary.

Panel: Cervical cancer vaccine passes the test

Pueblo Chieftain - 5/19/2006 12:33 PM

WASHINGTON - A vaccine that blocks viruses that cause most cervical cancer is safe and effective and should be approved, a federal panel recommended Thursday. The drug maker said the vaccine could slash global deaths from the No. 2 cancer in women by more than two-thirds.
 
A Food and Drug Administration advisory committee voted 13-0 on five separate times to endorse Merck and Co.’s Gardasil. The anticipated cost of the vaccine, administered in three shots over six months, is $300 to $500 - a possible impediment to widespread vaccination campaigns
 
· Read The Full Cancer Drugs Article From Pueblo Chieftain -->

· Read All Cancer Drugs News Stories -->

Comments On Cancer Drugs News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: